Mankind Pharma Ltd (MANKIND) — Cash Flow Reinvestment Rate
Mankind Pharma Ltd (MANKIND) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs2.19 Billion. Check cash flow quality index of Mankind Pharma Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Mankind Pharma Ltd Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Mankind Pharma Ltd across 7 annual periods. Explore Mankind Pharma Ltd (MANKIND) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Mankind Pharma Ltd (2019–2025)
Year-by-year capital reinvestment analysis for Mankind Pharma Ltd. For live market cap and broader valuation context, see how much is Mankind Pharma Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | Rs4.61 Billion | Rs24.13 Billion | Rs4.61 Billion | ▲ +7.5% |
| 2024 | 0.18x | Rs3.82 Billion | Rs21.52 Billion | Rs3.82 Billion | ▼ -61.3% |
| 2023 | 0.46x | Rs8.32 Billion | Rs18.13 Billion | Rs8.32 Billion | ▼ -88.6% |
| 2022 | 4.04x | Rs37.15 Billion | Rs9.20 Billion | Rs23.46 Billion | ▲ +199.3% |
| 2021 | 1.35x | Rs15.35 Billion | Rs11.37 Billion | Rs3.12 Billion | ▲ +116.4% |
| 2020 | 0.62x | Rs6.67 Billion | Rs10.70 Billion | Rs2.28 Billion | ▲ +25.8% |
| 2019 | 0.50x | Rs2.98 Billion | Rs6.00 Billion | Rs2.98 Billion | — |